| mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.8 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.01 |
0.8 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.9 |
| mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.9 |
| mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.9 |
| mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.9 |